002198.SZ
Guangdong Jiaying Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 3.26
−1.51%Year over year
Reported trailing growth
- Revenue
- -4.5%
- EBITDA
- —
- EBIT
- -12.4%
- EPS
- -18.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -16.5%
- EBITDA
- -7.5%
- EBIT
- -9.6%
- Net income
- -11.5%
- EPS
- -11.5%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026